HANCOCK WHITNEY CORP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 226 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$737,005
+6.4%
22,684
-17.5%
0.02%
+4.2%
Q1 2024$692,650
+78.8%
27,497
+130.5%
0.02%
+71.4%
Q4 2023$387,485
+19.0%
11,930
-0.2%
0.01%
+7.7%
Q3 2023$325,523
+18.4%
11,948
-3.5%
0.01%
+18.2%
Q2 2023$275,000
-27.2%
12,380
-29.1%
0.01%
-26.7%
Q1 2023$378,000
-7.1%
17,472
-12.8%
0.02%
-6.2%
Q4 2022$407,000
-21.1%
20,036
-0.4%
0.02%
-27.3%
Q3 2022$516,000
+5.5%
20,111
-2.3%
0.02%
+10.0%
Q2 2022$489,000
+1.7%
20,578
-3.7%
0.02%
+25.0%
Q1 2022$481,000
-5.7%
21,367
-17.0%
0.02%0.0%
Q4 2021$510,0000.0%25,733
-0.8%
0.02%
-11.1%
Q3 2021$510,000
-11.0%
25,936
-0.4%
0.02%0.0%
Q2 2021$573,000
-28.6%
26,029
-23.0%
0.02%
-33.3%
Q1 2021$803,000
-10.5%
33,784
-1.4%
0.03%
-10.0%
Q4 2020$897,000
+49.7%
34,268
-0.6%
0.03%
+36.4%
Q3 2020$599,000
+2.7%
34,465
-0.5%
0.02%0.0%
Q2 2020$583,000
+26.2%
34,636
-10.9%
0.02%
+22.2%
Q1 2020$462,000
+37.5%
38,877
+40.0%
0.02%
+63.6%
Q4 2019$336,000
-44.1%
27,760
-34.7%
0.01%
-45.0%
Q3 2019$601,000
+11.3%
42,520
-12.2%
0.02%
+17.6%
Q2 2019$540,00048,4220.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,372,001$98,287,0004.68%
TANAKA CAPITAL MANAGEMENT INC 79,574$934,0002.82%
Consonance Capital Management LP 3,747,453$43,995,0002.78%
S&T BANK/PA 613,740$7,205,0001.62%
AJ WEALTH STRATEGIES, LLC 595,834$6,995,0001.16%
Capital Impact Advisors, LLC 193,694$2,522,0001.12%
TEALWOOD ASSET MANAGEMENT INC 154,615$1,815,0000.77%
AMI ASSET MANAGEMENT CORP 722,932$8,487,0000.63%
Birchview Capital, LP 50,000$587,0000.37%
FEDERATED HERMES, INC. 11,176,281$131,210,0000.32%
View complete list of CORCEPT THERAPEUTICS INC shareholders